The study of atherosclerosis with ramipril and rosiglitazone.

Trial Profile

The study of atherosclerosis with ramipril and rosiglitazone.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2009

At a glance

  • Drugs Ramipril; Rosiglitazone
  • Indications Atherosclerosis; Glucose intolerance
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms STARR
  • Most Recent Events

    • 02 Jun 2009 Primary endpoint 'Intima media thickness' has not been met, according to results published in the Journal of the American College of Cardiology.
    • 02 Jun 2009 Results published in the Journal of the American College of Cardiology.
    • 24 Aug 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top